Delivery Order SPE2DX22D0010-SPE2D826FBQ46
- Not listed
- This delivery order, valued at $2,268.52, was awarded on August 29, 2025, by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp for the supply of Concerta ER Tablets 54mg. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 2, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- This delivery order, valued at $1,503.90, was awarded to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Concerta ER 54 mg tablets (100-unit quantity). The contract is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, executed through the Defense Logistics Agency's medical supply chain. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this...
- This delivery order, valued at $1,832.92, represents a competitive, non-set-aside award to AmerisourceBergen Drug Corp for the supply of Concerta ER Tabs 54mg. The contract was awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, and operates under firm fixed pricing terms. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award is funded through the Defense Logistics Agency's Medical Supply Chain, which...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,397.53 for 100 tablets of Concerta ER 36 mg on December 8, 2025, with completion expected by December 9, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply transaction under AmerisourceBergen's larger contract vehicle with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Concerta ER Tablets 36mg with a ceiling value of $15,818.06. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle and involves no set-aside designation. The award was made competitively and will be performed at the...
- The Defense Logistics Agency awarded a $2,826.19 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 27 mg on May 2, 2025, with a completion date of May 5, 2025. This contract is a firm fixed price delivery order with no set-aside designation, competitively awarded to fulfill pharmaceutical supply needs for federal medical procurement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) valued at $10,648.92 under a firm fixed price contract. This is a non-set-aside, competitively awarded delivery order with a completion date of August 6, 2025, and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Concerta ER 36 mg tablets (100-count units) with a ceiling value of $8,094.42. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award does not carry a set-aside designation, reflecting the vendor's demonstrated...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Concerta ER Tabs 36mg pharmaceutical products. This firm fixed-price delivery order, valued at $20,665.92, is scheduled for completion by October 31, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The award was made on a competitive basis without any set-aside designation, reflecting...
- This delivery order, awarded on August 12, 2025, to AmerisourceBergen Drug Corp for $2,788.06 represents a pharmaceutical supply transaction under the Defense Logistics Agency's Medical Supply Chain operations. The award covers Concerta ER Tabs 54mg, a controlled-release methylphenidate medication commonly used in military and veteran healthcare settings. Utilizing firm fixed pricing with no set-aside designation, this competitive award reflects AmerisourceBergen's ongoing role as a critical...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBQ46Delivery Order
This delivery order awards AmerisourceBergen Drug Corp $2,156.95 for the supply of Concerta ER Tablets 54mg under a competitive, non-set-aside contract. The contract was awarded on December 9, 2025, with an ultimate completion date of December 10, 2025, and is funded through the Defense Logistics Agency's Medical Supply Chain. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. The firm fixed price structure reflects standard federal pharmaceutical procurement practices for this category of controlled pharmaceutical supply. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal healthcare systems, AmerisourceBergen Drug Corp fulfills critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government entities through this comprehensive global pharmaceutical support vehicle. The award demonstrates the contractor's continued capability to meet competitive federal procurement requirements for pharmaceutical products supporting military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 12/8/25 |